Who invested in Zhenge Biotech?
Zhenge Biotech's investors include Goldman Sachs, Qiming Venture Partners, IDG Capital, Korea Investment Partners and Novo Holdings, and 1 more on record.
Who invested in Zhenge Biotech
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2022, from 1 source
- Latest round
- Series C, $15MAug 2022
- Investors
- 6
The rounds
- Aug 2022
Everyone who backed them
Goldman Sachs AssetmanagementVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Zhenge Biotech
How much has Zhenge Biotech raised?
Zhenge Biotech has raised $15M across 1 round since 2022.
When did Zhenge Biotech last raise?
Zhenge Biotech's most recent round was a Series C of $15M in Aug 2022.
What was Zhenge Biotech's biggest round?
Its most recent round, $15M in Aug 2022, is also its largest on record.
Who backed Zhenge Biotech first?
Zhenge Biotech's first round on record, in Aug 2022, was backed by Goldman Sachs, Qiming Venture Partners and IDG Capital and 3 others.
What stage is Zhenge Biotech at?
Zhenge Biotech's latest named round is a Series C, in Aug 2022.
Companies like Zhenge Biotech
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.